Imipramine N-oxide hydrate
CAS: 6829-98-7
Ref. 3D-FI24562
1mg | 136.00 € | ||
2mg | 188.00 € | ||
5mg | 325.00 € | ||
10mg | 452.00 € | ||
25mg | 905.00 € |
Product Information
- 10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine N-Oxide hydrate
- 10,11-Dihydro-N,N-dimethyl-5H-dibenz(b,f)azepine-5-propanamine N-oxide
- 5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine 5-oxide
- 5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine N-oxide
- 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-10,11-dihydro-, N-oxide
- 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-, N-oxide
- Elepsin
- Imipramine N-oxide
- Imipramine oxide
- Imipraminoxide [INN]
- See more synonyms
- Imipraminoxido
- Imipraminoxido [INN-Spanish]
- Imipraminoxidum
- Imipraminoxidum [INN-Latin]
- N,N-dimethyl-3-(5-oxido-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propan-1-amine
- Unii-8Mks280Xjw
- [3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]dimethylamine oxide
- Imipraminoxide
Imipramine N-oxide hydrate is a polymer drug that belongs to the group of amines. It inhibits the activity of CYP450 enzymes and has been shown to be effective in treating inflammatory bowel disease (IBD). Imipramine N-oxide hydrate prevents adenosine A3 receptor activation and suppresses the production of dinucleotide phosphate, which may be responsible for its effectiveness in treating IBD. Imipramine N-oxide hydrate also has an effect on liver cells, which may lead to its effectiveness in treating infectious diseases. The drug is not active against autoimmune diseases, but it may have an effect on toll-like receptors.
Chemical properties
Technical inquiry about: 3D-FI24562 Imipramine N-oxide hydrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.